ArticleInflammatory bowel diseases2019

Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease".

Renske W M Pauwels et al.PubMed ↗Publisher ↗

No numbers read from the abstract.